| Satrix Healthcare Innovation Feeder ETF
Type: Passive ETF |
JSE code: STXHLT |
| Benchmark: STOXX Global Breakthrough Healthcare Index | Classification: Global Equity |
| Tax-free investing: Allowed (What is tax-free?) | Market cap: R 104 million |
| TIC (TER where TIC not indicated): 50.00% (What is TER?) | Distribution: Fund does not distribute: N/A |
| Top holdings:
Ucb Sa 2.27, Genmab 2.05, Beone Medicines Ag 2.01, Abbvie Inc 1.89, Iqvia Holdings Inc 1.84, Johnson & Johnson 1.83, Thermo Fisher Scientific Inc 1.81, Neurocrine Biosciences Inc 1.74, Medtronic Plc 1.68, Illumina Inc 1.67 |
|
| MDD updated: 31-Oct-25 (Understanding your MDD) | |
| Description:
The mandate is to track, as closely as possible, the value of the STOXX Global Breakthrough Healthcare Index in ZAR. This index is composed of companies at the forefront of biotech, medical devices and healthcare services in developed and emerging markets, screened to meet minimum ESG criteria. To replicate the index performance, the ETF invests in the iShares Healthcare Innovation UCITS ETF USD (the underlying fund). Performance may be affected by transactions, exchange rates, and differing pricing points. |
|
All data from the issuer Minimum Disclosure Documents (MDD) and updated as they update their MDDs. Please check all data, we take no responsibility for errors.